drugset
drugset / Trial / NCT02869672

Safety and Immunogenicity Study of ACYW135 Meningococcal Polysaccharide Vaccine Aged 2-50 Years Old

NCT02869672 ↗

Phase 3 Unknown 1200 enrolled Beijing Chaoyang District Centre for Disease Control and Prevention
RandomizedParallel-groupDouble-blindPrevention

Summary

This study evaluates the safety and immunogenicity of the ACYW135 Meningococcal Polysaccharide Vaccine in population aged 2-50 years old. Subjects will be divided into 3 group according to their age, receiving the test vaccine and the control vaccine at the proportion of 1:1 randomly. Each age group has 400 subjects, 1200 in total.

Timeline

Start
2016-07
Primary completion
2016-12
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hualan Biology ACYW135 meningococcal polysaccharide vaccine Vaccine 0.5 ml Intramuscular
Subject Tiantan Biology ACYW135 meningococcal polysaccharide vaccine Vaccine 0.5 ml Intramuscular

Indications

No indication recorded.